Solana Company expects first validator-related rewards in Q3 2026 as 0.5 million SOL stake commitment supports Tokyo cluster (NASDAQ:HSDT)August 15, 2026
Share Facebook Twitter LinkedIn Pinterest Email Bristol Myers scraps Phase 3 study for Opdualog for colorectal cancer
Solana Company expects first validator-related rewards in Q3 2026 as 0.5 million SOL stake commitment supports Tokyo cluster (NASDAQ:HSDT)August 15, 2026
Nerdy announces 1-for-15 reverse stock split to meet NYSE minimum share price requirementAugust 14, 2026
Fed rate hike odds sink further as retail sales, consumer sentiment fall (US2Y:) (US2Y:) (US2Y:) (US2Y:)August 14, 2026
